siTools Biotech

siTools Biotech

Munich, Germany· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $2.5M

Overview

siTOOLs Biotech is a privately held, revenue-generating tools and services company operating in the RNA research and genomics sector. Its core technology platform revolves around designing highly specific, complex pools of oligonucleotides (siRNAs and rRNA probes) to enable efficient gene silencing and sample preparation for next-generation sequencing. With a global distributor network and a product portfolio validated in high-impact publications, the company is positioned as a specialized provider for the growing functional genomics and RNA therapeutics research market. Its business model is based on the sale of research-use-only kits and custom services, not therapeutic development.

RNA TherapeuticsGenetics & Genomics

Technology Platform

Proprietary bioinformatics platform for designing complex, highly specific oligonucleotide pools for gene silencing (siPOOLs) and ribosomal RNA depletion (riboPOOLs), adaptable to any gene or species.

Funding History

2
Total raised:$2.5M
Seed$2M
Grant$500K

Opportunities

The growing fields of functional genomics and RNA therapeutics drive demand for reliable gene silencing and RNA-seq tools.
The company's ability to tailor products for non-model organisms and complex samples addresses underserved niche markets.
Expansion of its product line into complete workflow solutions (like the ARGO kit) can increase average revenue per customer.

Risk Factors

Intense competition from large, well-capitalized life science tools companies poses a constant threat.
Technological disruption, such as the widespread adoption of CRISPR-based screening over RNAi, could reduce demand for core siRNA products.
The business is vulnerable to fluctuations in global academic and biopharma research funding.

Competitive Landscape

siTOOLs competes in the research tools segment against giants like Thermo Fisher (Dharmacon), Horizon Discovery, and Qiagen, as well as numerous NGS library prep specialists. Its differentiation is its focus on complex, bioinformatically optimized pools for specificity and its customizability for non-standard research applications, a niche larger players often overlook.